August 24, 2020 10:34 AM EDT
Deals

Vir en­lists Covid-19 an­ti­body ri­val for can­cer, in­fec­tious dis­ease dis­cov­ery work

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CRISPR patent spat re­vived by fed­er­al ap­peals court rul­ing

Unit­ed­Health Group CEO An­drew Wit­ty steps down

HHS fo­cus­es on 'trans­paren­cy' in third-round IRA ne­go­ti­a­tion guid­ance

TIG­IT grave­yard ex­pands as GSK drops late-stage as­set with iTeos

Some gener­ics, biosim­i­lar drug­mak­ers say they can with­stand tar­iff im­pact

Bay­er starts 2025 by cut­ting 2,000 jobs as it homes in on year-end re­haul tar­get

A service from the Financial Times